PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease

2024-06-01
(Press-News.org) BOSTON—People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Heart disease is a major cause of death in people with type 1 diabetes, especially in those who develop kidney complications from diabetes.

“As people with type 1 diabetes live longer due to improved medical care, a substantial proportion of these patients survive without kidney complications, but are still at high risk for heart disease,” said lead researcher Marc Gregory Yu, M.D., of the Joslin Diabetes Center and Harvard Medical School in Boston, Mass.

Yu and colleagues examined data from a patient group known as the “Medalists,” consisting of more than 1,000 individuals from across the United States who have had type 1 diabetes for over 50 years. The “Medalists” are noteworthy because only 13% have kidney complications from diabetes, and most also have excellent control of blood pressure, cholesterol, and blood sugar levels—all traditional risk factors for heart disease. Despite this, around 40% of them still report having heart disease.

From the overall study group of more than 1,000 people, 153 underwent CT scans to detect calcium deposits in the heart’s blood vessels, and 111 underwent MRI imaging to evaluate the heart’s overall structure and pumping capacity. The “Medalists” had higher calcium deposits in the heart’s blood vessels, although with comparable heart structure and function, compared to other individuals of a similar age with type 1 or type 2 diabetes. Higher blood sugar levels among the Medalists were also observed to be closely linked to heart disease. “This highlights the continued importance of blood sugar control in type 1 diabetes despite advancing age,” Yu said.

“We likewise observed that risk factors for heart disease may differ among the ‘Medalists’ when they were grouped according to those who have and don’t have kidney complications from diabetes,” Yu said. “These risk factors may also be different for type 1 diabetes in general, as compared to type 2 diabetes. The findings may help guide the development of new medications specifically targeted for heart disease in type 1 diabetes.”

###

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

END


ELSE PRESS RELEASES FROM THIS DATE:

GLP-1 medications for type 2 diabetes and obesity may lower risk of acute pancreatitis

2024-06-01
BOSTON—Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. Doctors have been cautious about prescribing these medications in patients with a history of pancreatitis due to the potential risk of worsening the condition – a warning that is included in prescribing information, said lead researcher Mahmoud Nassar, M.D., Ph.D., Department of Medicine ...

Anti-obesity medication tirzepatide remains effective even for those with diabetes and other complications

2024-06-01
BOSTON—Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.  Obesity causes or worsens over 200 diseases. It has been widely believed that when patients suffer multiple medical problems, they are not able to lose as much weight as those without medical issues. The new study, funded by tirzepatide maker Eli Lilly Inc., was designed to see if having more obesity-associated ...

Risk for heart attack and stroke increases in people with obesity for a decade or more

2024-06-01
BOSTON—People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “It is well established that people who have excess weight at any point in time have a greater risk of heart attacks and strokes. What was not known was whether it matters for how long someone has been exposed to excess weight,” said Alexander Turchin, M.D., M.S., Director of Quality at the Division of Endocrinology at Brigham & Women’s ...

Asian patients more likely to develop type 2 diabetes 1 year after prediabetes diagnosis compared to white and Black patients

2024-06-01
BOSTON—One year after a prediabetes diagnosis, Asians were more likely to develop diabetes mellitus whereas Black patients were more likely to remain in prediabetes range, highlighting racial disparities in diabetes prevention, according to data presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Every year a small proportion of patients with prediabetes will progress to diabetes mellitus with some proportion of patients reverting to normal glucose levels,” said Ewelina Niedzialkowska, M.D., an internal medicine resident at Corewell Health William Beaumont University Hospital, in Royal Oak, Mich. “While diet, lifestyle ...

Synthetic estrogen associated with increased anxiety-like behaviors in a rat model

2024-06-01
BOSTON—The type of estrogen in hormonal birth control may influence anxiety-like behaviors, according to data presented by Abigail Hegwood, M.S., from the Prakapenka Lab at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “It is plausible that estrogen type is a key player in mood or cognitive related side effects of hormone-based contraceptive use,” said Alesia Prakapenka, Ph.D., an assistant professor in the Biomedical Sciences program at Midwestern University in Downers Grove, Ill. According to the CDC, 12.6% of women in the United States between the ages of 15 and 49 reported using oral contraceptives from ...

Revolutionizing robotics: A breakthrough in soft actuator technology

Revolutionizing robotics: A breakthrough in soft actuator technology
2024-06-01
In an era where robotics are increasingly becoming a part of everyday life, a significant breakthrough has been made by a team of researchers at Zhe jiang University, China. Their latest creation, a wrist-inspired soft actuator capable of bidirectional torsion, promises to transform the landscape of soft robotics. The innovative design of this actuator, described in detail in the journal Cyborg Bionic Systems, is inspired by the human wrist's ability to perform complex movements. Unlike traditional robotic mechanisms that rely on rigid components, this soft actuator utilizes a magneto-pneumatic hybrid system combined with a Kresling origami structure. This design allows for an astonishing ...

Huazhong University unveils breakthrough in rapid topology identification for complex networks

Huazhong University unveils breakthrough in rapid topology identification for complex networks
2024-06-01
Researchers from Huazhong University of Science and Technology, in collaboration with the Donders Institute for Brain, Cognition and Behavior at Radboud University, have developed a revolutionary method for the rapid identification of network topologies. Their new approach, detailed in a recent publication in Cyborg Bionic Systems, significantly accelerates the process of understanding complex dynamical networks, which are crucial in numerous applications ranging from power grids to transportation systems. The innovative method, named Finite-Time Topology Identification of Delayed Complex Dynamical Networks (FT-TIDCN), leverages finite-time stability ...

Prediabetes raises Mexicans’ risk of dying prematurely of heart or kidney disease

2024-06-01
BOSTON—Prediabetes increases the risk of dying before age 75, particularly due to heart disease, kidney disease and acute diabetic complications, according to a new study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Prediabetes is well known to increase the risk of developing diabetes; however, information about other complications of prediabetes in Latin America was limited before this study,” said study researcher Carlos Fermin-Martinez, M.D., of the National Autonomous University of Mexico in Mexico City, Mexico. He is also with the National Institute of Geriatrics in Mexico ...

GLP-1 has the power to change taste sensitivity in women with obesity

2024-06-01
BOSTON—Semaglutide improved taste sensitivity, changed gene expression in the tongue that’s responsible for taste perception, and changed the brain’s response to sweet tastes, according to research presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “People with obesity often perceive tastes less ‘intensely,’ and they have an inherently elevated desire for sweet and energy-dense food,” said Mojca Jensterle Sever, Ph.D., of the University Medical Centre in Ljubljana, Slovenia. Jensterle Sever and colleagues designed a proof-of-concept study on the impact of GLP-1 ...

Race and social vulnerability impact glycemic control in people with diabetes

2024-06-01
BOSTON—People of color and those who experience social vulnerability are more likely to experience worse glycemic control than their white counterparts, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “As of 2021, 29.7 million people were living with diabetes, contributing to significant morbidity across the population. Despite advances in diabetic care, marginalized populations bear an increased burden of diabetic complications,” said study author Jennifer Tich, M.D., from Internal Medicine-Pediatrics R3 at the University of Rochester in Rochester, N.Y. Tich and colleagues identified ...

LAST 30 PRESS RELEASES:

Maternal perinatal depression may increase the risk of autistic-related traits in girls

Study: Blocking a key protein may create novel form of stress in cancer cells and re-sensitize chemo-resistant tumors

HRT via skin is best treatment for low bone density in women whose periods have stopped due to anorexia or exercise, says study

Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research

From rice fields to fresh air: Transforming agricultural waste into a shield against indoor pollution

University of Houston study offers potential new targets to identify, remediate dyslexia

Scientists uncover hidden role of microalgae in spreading antibiotic resistance in waterways

Turning orange waste into powerful water-cleaning material

Papadelis to lead new pediatric brain research center

Power of tiny molecular 'flycatcher' surprises through disorder

Before crisis strikes — smartwatch tracks triggers for opioid misuse

Statins do not cause the majority of side effects listed in package leaflets

UC Riverside doctoral student awarded prestigious DOE fellowship

UMD team finds E. coli, other pathogens in Potomac River after sewage spill

New vaccine platform promotes rare protective B cells

Apes share human ability to imagine

Major step toward a quantum-secure internet demonstrated over city-scale distance

Increasing toxicity trends impede progress in global pesticide reduction commitments

Methane jump wasn’t just emissions — the atmosphere (temporarily) stopped breaking it down

Flexible governance for biological data is needed to reduce AI’s biosecurity risks

Increasing pesticide toxicity threatens UN goal of global biodiversity protection by 2030

How “invisible” vaccine scaffolding boosts HIV immune response

Study reveals the extent of rare earthquakes in deep layer below Earth’s crust

Boston College scientists help explain why methane spiked in the early 2020s

Penn Nursing study identifies key predictors for chronic opioid use following surgery

KTU researcher’s study: Why Nobel Prize-level materials have yet to reach industry

Research spotlight: Interplay of hormonal contraceptive use, stress and cardiovascular risk in women

Pennington Biomedical’s Dr. Catherine Prater awarded postdoctoral fellowship from the American Heart Association

AI agents debate more effectively when given personalities and the ability to interrupt

Tenecteplase for acute non–large vessel occlusion 4.5 to 24 hours after ischemic stroke

[Press-News.org] People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease